What is the National Institutes of Health Stroke Scale (NIHSS) score?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is the NIHSS Score?

The National Institutes of Health Stroke Scale (NIHSS) is a standardized 42-point assessment tool that quantifies neurological deficits after stroke, where higher scores indicate more severe neurological impairment, and it serves as the primary instrument for guiding acute stroke treatment decisions and predicting patient outcomes. 1, 2

Core Structure and Components

  • The NIHSS consists of 11 core items that evaluate specific neurological domains including level of consciousness, visual fields, extraocular movements, facial palsy, motor function (arms and legs), sensory function, language, dysarthria, and extinction/inattention 3, 2

  • The scale ranges from 0 to 42 points total, with each item scored individually based on standardized criteria 1

  • An additional item assessing finger extension is often added to evaluate distal upper extremity weakness, which is more common than proximal arm weakness in stroke patients 2

  • Administration takes only 5-10 minutes and is based solely on examination without requiring historical information or input from family members 2

Scoring Interpretation and Prognostic Value

Scores greater than 16 forecast a high probability of death or severe disability, while scores less than 6 forecast good recovery. 1, 3, 2

  • The scale provides three severity categories: good (0-6 points), moderate (7-15 points), and poor (≥16 points) 4

  • Initial NIHSS scores strongly predict the likelihood of patient recovery and are used to guide critical decisions about acute stroke therapy, including eligibility for thrombolytic treatment 1, 3

  • During the first week after acute ischemic stroke, the NIHSS can identify patients highly likely to have poor outcomes 1

Clinical Applications and Timing

The American Heart Association strongly recommends performing the NIHSS at three critical timepoints: at presentation/hospital admission (or within 24 hours), at acute care discharge, and upon transfer to rehabilitation if previous scores are unavailable. 1, 3, 2

  • A 4-point improvement or worsening from baseline may alter treatment eligibility and should trigger reassessment of the patient's management plan 1, 3

  • The scale is particularly valuable for stratifying patients according to severity and likely outcome in both clinical practice and research settings 1

Administration Requirements and Certification

  • All professionals involved in stroke care (physicians, nurses, therapists, social workers) should be trained and certified to administer the NIHSS 1, 3, 2

  • Certification is achieved by watching a training videotape and passing an examination that involves scoring patients shown on a test tape 1, 2

  • The scale demonstrates high inter-rater reliability between certified examiners for most items, making it highly reproducible across different healthcare settings 1, 2

Important Limitations and Caveats

The NIHSS was designed primarily for anterior-circulation ischemic stroke evaluation and may underestimate the severity of posterior-circulation strokes. 1, 3

  • Posterior-circulation symptoms such as vertigo, difficulty swallowing (dysphagia), and balance disorders are not adequately captured by the standard scale 1, 3

  • Two items—facial palsy and dysarthria—have demonstrated lower inter-rater reliability compared to other components 3

  • Distal motor function and gait disorders are not comprehensively covered by the standard scale, potentially requiring additional assessments 3

  • A standardized grading system for posterior-circulation strokes is not currently available, which is a recognized gap in stroke assessment 1

Development and Validation

  • The NIHSS was developed by researchers at the National Institute of Neurological Disorders and Stroke (NINDS) specifically for use in clinical stroke trials 1

  • The scale has been extensively validated and standardized to reduce interobserver error across multiple clinical trials 1

  • Ongoing validation of the predictive value of the NIHSS through prospective data collection is encouraged to maintain its clinical utility 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Role of the NIH Stroke Scale in Stroke Assessment and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

NIH Stroke Scale Administration and Interpretation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.